Abstract
The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.
| Original language | English |
|---|---|
| Pages (from-to) | 2960-2964 |
| Number of pages | 5 |
| Journal | Gan to kagaku ryoho. Cancer & chemotherapy |
| Volume | 13 |
| Issue number | 10 |
| Publication status | Published - Oct 1986 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Pharmacology
Cite this
Non-Hodgkin's lymphoma : correlation of cell surface marker phenotype with clinical features and prognosis. / Okabe, K.; Toki, H.; Kimura, Y.; Fujii, M.; Kiura, Katsuyuki; Moriwaki, S.
In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 13, No. 10, 10.1986, p. 2960-2964.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Non-Hodgkin's lymphoma
T2 - correlation of cell surface marker phenotype with clinical features and prognosis
AU - Okabe, K.
AU - Toki, H.
AU - Kimura, Y.
AU - Fujii, M.
AU - Kiura, Katsuyuki
AU - Moriwaki, S.
PY - 1986/10
Y1 - 1986/10
N2 - The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.
AB - The correlation of surface marker phenotype with prognosis was analysed in 64 patients with non-Hodgkin's lymphoma who had been treated in Shikoku Cancer Center Hospital. B-cell lymphomas (21 cases) had significantly better prognosis than T-cell lymphomas (21 cases). The complete remission (CR) rate was 52%, and the 50% survival time was 13 months for T-cell lymphomas. All T-cell lymphoma patients died within 31 months. In B-cell lymphomas, on the other hand, the CR rate was 100%, 50% survival time was 30 months, and there were no cases of relapse in patients who had been in continuous CR for more than 2 years. About 40% of B-cell lymphomas appeared to have the potential for cure.
UR - http://www.scopus.com/inward/record.url?scp=0022792852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022792852&partnerID=8YFLogxK
M3 - Article
C2 - 3490224
AN - SCOPUS:0022792852
VL - 13
SP - 2960
EP - 2964
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 10
ER -